About
Runatek has designed the first outpatient, wearable, smart drug delivery device with feedback control, the Sotiras. We have patents pending on our technology. Its initial market is acute care pain management after total joint replacement surgery, with the cost covered by the insurance provider. We are a less risky, more effective alternative to opioid tablets, with much better control over these restricted and potentially addictive drugs.
Technologies
Gmail
Google Apps
Google Cloud Hosting
Wix
Mobile Friendly
Varnish
Node.js
Android
Remote
Basis
SharePoint
Flutter
Python
AI
IoT
Keywords
venture capital funding
healthcare analytics
pain management
feedback control
opioid alternative
patent pending
outpatient total joint replacement
medtech
wearable drug delivery device
b2b
medical devices
biotechnology
feedback control technology
smart drug delivery
fda approval process
opioid reduction
post-surgical pain
medical equipment and supplies manufacturing
healthcare technology
outpatient pain relief
insurance-covered cost
medtech startup
healthcare equipment and supplies
fda clearance
market growth
wearable medical device
medical device innovation
acute care pain management
medical technology
healthcare
Company Information
-
Employees 4
Location
9304 Forest Ln, Dallas, Texas, United States, 75243-4237